Biotin Scientific References and Clinical Study Library

Krishna Vasani
October 31, 2026
7 min read

Biotin Scientific References and Clinical Study Library

Claims about hair, skin, nails and energy metabolism are everywhere, but the evidence behind them is rarely shown. This page collects the biotin scientific references behind our content so you can check every claim yourself. Each entry names the study type, the population and the dose studied. Evidence for biotin is uneven: it is strong for deficiency and for lab-test interference, and weaker for cosmetic benefits in healthy people. Reading the original papers, not headlines, is the best way to see that difference.

1. How This Biotin Research Library Is Organized

Biotin (vitamin B7) is a water-soluble B vitamin that acts as a coenzyme for five carboxylase enzymes involved in fatty acid, glucose and amino acid metabolism. Sources are grouped from highest to lowest strength of evidence for human decisions:

Systematic reviews and meta-analyses
Randomized controlled trials (RCTs)
Observational human studies
Pharmacokinetic and safety studies
Mechanistic and preclinical studies

Official sources (NIH, FDA, EFSA, Institute of Medicine) are listed separately because they set intake values and safety guidance. Where we could not confirm a persistent identifier (DOI) at the time of review, we link to a PubMed search for the citation instead of guessing. Always confirm details against the original paper.

2. Systematic Reviews on Biotin

Systematic reviews collect studies using a defined method. For biotin, the most cited review for the hair and nail question is:

Patel DP, Swink SM, Castelo-Soccio L. "A Review of the Use of Biotin for Hair Loss." Skin Appendage Disorders, 2017. It reviewed published reports and concluded that biotin supplementation has been documented mainly in people with a true deficiency or a genetic disorder of biotin metabolism. Evidence for healthy people with normal biotin status is limited and low quality.

Key takeaway: no high-certainty systematic review shows that biotin regrows hair in people who are not deficient.

3. Meta-Analyses

At the time of review (October 2026), we did not identify a widely accepted meta-analysis that pools randomized trials of biotin alone for hair, skin or nails in healthy adults. This is itself informative: the trials are too few, too small and too different in design to pool well. Meta-analyses of multi-ingredient supplements (for example, products combining biotin with zinc, marine proteins or silica) exist, but they cannot isolate biotin's effect. We will add a meta-analysis here once a rigorous one is published.

4. Randomized Controlled Trials on Biotin Clinical Studies

Randomized, placebo-controlled trials are the best test of whether biotin works. The main areas studied are neurology and hair or nail health.

Progressive multiple sclerosis (high-dose pharmaceutical biotin, MD1003)

Tourbah A, et al. "MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study." Multiple Sclerosis Journal, 2016 (MS-SPI trial, about 150 participants, 300 mg/day).
Cree BAC, et al. Phase 3 SPI2 trial of MD1003 in progressive MS, Multiple Sclerosis Journal, 2020. The larger trial did not confirm the earlier signal on its primary measures.

Hair and nails

Glynis A. "A double-blind, placebo-controlled study evaluating the efficacy of an oral supplement in women with self-perceived thinning hair." Journal of Clinical and Aesthetic Dermatology, 2012. The supplement was a multi-ingredient product, so the effect cannot be attributed to biotin.
Small older studies on brittle nails (for example, Colombo VE et al., Cutis, 1990) reported improved nail thickness with oral biotin, but they were small, short and not placebo-controlled to modern standards.

Key takeaway: high-dose biotin has been tested seriously in MS with mixed results, while evidence for cosmetic use rests on small or multi-ingredient studies.

5. Observational Human Studies

Observational work looks at biotin status or intake without assigning treatment. Useful themes include:

Marginal biotin deficiency during normal pregnancy, studied by Donald Mock and colleagues, which suggested a subclinical decline in biotin status in some pregnant women.
Case reports and case series of deficiency linked to prolonged raw egg-white intake (avidin binds biotin), long-term anticonvulsant use, parenteral nutrition without biotin, and biotinidase deficiency.
Reports describing falsely abnormal thyroid, cardiac troponin and hormone test results in people taking biotin supplements.

Observational studies can show association, not cause, so we treat them as supporting evidence only. Laboratory professional examining a blood sample beside an automated analyzer and racks of specimen tubes.

6. Pharmacokinetic Studies

Zempleni J, Mock DM. "Bioavailability of biotin given orally to humans in pharmacologic doses." American Journal of Clinical Nutrition, 1999. Oral biotin is well absorbed even at pharmacologic doses, and the excess is cleared mainly through the kidneys.
Mock DM. "Biotin: from nutrition to therapeutics." Journal of Nutrition, 2017. A comprehensive review of absorption, transport, catabolism and therapeutic use.

Because biotin is water-soluble and excreted in urine, it does not accumulate the way fat-soluble vitamins can. That is the reason no tolerable upper intake level has been set, but it does not mean every dose is free of consequences, as the next section shows.

7. Biotin Safety and Toxicology Studies

The most important safety finding concerns laboratory tests, not organ toxicity.

Li D, et al. "Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults." JAMA, 2017. After healthy adults took supplemental biotin, several streptavidin-biotin immunoassays gave falsely high or falsely low results.
U.S. FDA Safety Communication (2017, updated 2019): biotin in supplements can interfere with lab tests and cause incorrect results, including troponin tests used in heart attack diagnosis.

Practical point: tell your clinician and laboratory about any biotin supplement before blood tests. Many labs advise stopping high-dose biotin for a period before testing, but follow the instructions of your own clinician.

8. Mechanistic Studies

Zempleni J, Wijeratne SSK, Hassan YI. "Biotin." BioFactors, 2009. Describes biotin's role as a coenzyme for acetyl-CoA carboxylases, pyruvate carboxylase, propionyl-CoA carboxylase and 3-methylcrotonyl-CoA carboxylase, plus its role in histone biotinylation and gene regulation.
Studies of biotinidase and holocarboxylase synthetase deficiencies explain why inherited biotin-recycling disorders produce skin rash, hair loss and neurological signs, and respond to biotin treatment.

9. Preclinical Studies

Animal and cell studies show how biotin deficiency affects fat metabolism, glucose handling, immune function and development. Because doses, species and metabolism differ, preclinical findings generate hypotheses and should not be read as proof of benefit in people. We list them here for completeness but never use them as the sole basis for a human health claim.

10. Study Table: Year, Design, Population and Dose

Year	Reference (short)	Design	Population	Dose / exposure
1990	Colombo et al., Cutis	Small clinical study	Adults with brittle nails	Oral biotin (supplemental)
1999	Zempleni & Mock, AJCN	Pharmacokinetic study	Healthy adults	Oral pharmacologic doses
2009	Zempleni et al., BioFactors	Narrative review	Mechanistic / general	Not applicable
2012	Glynis, J Clin Aesthet Dermatol	RCT (multi-ingredient)	Women with self-perceived thinning hair	Combination supplement
2016	Tourbah et al., Mult Scler	RCT	Progressive MS	300 mg/day MD1003
2017	Patel et al., Skin Appendage Disord	Systematic-style review	Hair loss literature	Varied
2017	Li et al., JAMA	Interference study	Healthy adults	Supplemental biotin
2017	Mock, J Nutr	Narrative review	Nutrition and therapeutics	Varied
2020	Cree et al., Mult Scler (SPI2)	Phase 3 RCT	Progressive MS	High-dose MD1003

For context, official adequate intake values are about 30 micrograms per day for adults (Institute of Medicine) and 40 micrograms per day (EFSA). Supplements often contain 5,000 to 10,000 micrograms, and the MS trials used 300,000 micrograms. Doctor and healthcare colleague reviewing brain scan images and medical charts on a tablet during a consultation with a patient.

11. DOI, PubMed and Official Links

Verified official sources:

NIH Office of Dietary Supplements, Biotin fact sheet for health professionals: https://ods.od.nih.gov/factsheets/Biotin-HealthProfessional/
U.S. FDA, safety communication on biotin interference with lab tests: https://www.fda.gov/medical-devices/safety-communications
EFSA, Dietary reference values for biotin: https://www.efsa.europa.eu
PubMed (search each citation above by title and first author): https://pubmed.ncbi.nlm.nih.gov/

Example PubMed searches:

Take the Next Step With Biotin Research You Can Trust

Use this library as your starting point: open the primary papers, compare the dose and population with your own situation, and be cautious about any claim that cannot be traced to a study. If you take a supplement, discuss it with your clinician, especially before blood tests. Bookmark this page and check the update log for new biotin clinical studies.